Cross-linked Emulsion Study
A Pilot Study on the Effect of Protein Cross-linking on Gastric Layering and Emptying of a Food Emulsion
1 other identifier
interventional
4
1 country
1
Brief Summary
This comparative pilot study is designed to compare the rates of gastric emptying and by inference rates of digestion of two food emulsions. Two types of milk protein stabilised food emulsion will be compared, one standard emulsion preparation and one emulsion preparation cross-linked with microbial transglutaminase. The information from this study will then be compared to data on satiety and endocrine hormones from a parallel study undertaken in Finland using the same two meal formulations. The drinks will be labeled with a stable isotope of carbon and samples of breath collected every 20 minutes after consumption of the drink. This will allow gastric residence time to be calculated. The pilot will also fulfill two secondary objectives. At the same time as the breath samples are collected MRI scans of the upper abdomen will be made so that gastric volumes can be measured in order to compare the two methods of measuring gastric emptying rates. Additionally, samples of saliva will also be collected after every MRI scan for subsequent mass spectrometry analysis. These are to assess the efficacy of mass spectrometry analysis for detection of the presence of specific digestion related hormones such as ghrelin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy-volunteers
Started Nov 2010
Typical duration for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 8, 2011
CompletedFirst Posted
Study publicly available on registry
April 11, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedJune 22, 2012
June 1, 2012
1.6 years
April 8, 2011
June 21, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of gastric emptying by MRI
rate measured from MRI images of gastric contents
20 minute intervals over 3 hours
Secondary Outcomes (2)
Gastric emptying by C13
every 20 minutes over 3 hours
mass spectrometry detection of GI tract hormones in saliva
every 20 minutes over 3 hours
Study Arms (1)
transglutaminase cross-linking of emulsion
EXPERIMENTALThe impact of enzyme cross linking of the protein stabilising the test emulsion on gastric emptying rate will be assessed. In this crossover study the subjects will also consume ( on a separate day)an emulsion of the same formulation but not cross-linked.
Interventions
This study will assess whether a subtle change in food structure (cross-linking of interfacial protein) can alter gastric emptying rate.
Eligibility Criteria
You may qualify if:
- Male (hormonal status of women would introduce more variation within small group)
- Age 20-50 years
- BMI 19-30
- Apparently healthy
- Normally eat lunch
- Willing to eat the "milkshake" style emulsion
- Provides written informed consent
You may not qualify if:
- You have an allergy or intolerance to rape seed oil, milk or milk proteins including lactose
- Smokers or smoked within the last year (smoking affects satiety/hunger)
- Diagnosed with any long term illness requiring active treatment e.g. diabetes, cancer, cardiovascular disease
- Have had surgery on the stomach or intestine or suffered from gastrointestinal disease, whether diagnosed or self reported
- A history of TB or hepatitis.
- Regular (more than once in 10 days) use of antacids, laxatives
- Diagnosis with any mouth, dental, throat or digestive problem that may affect normal eating and digestion of food.
- Take prescription medication for digestive or gastrointestinal conditions.
- Volunteers taking part in another study (other than a questionnaire based study).
- Blood pressure greater than 160/100 or less than 90/50 or 95/55 if symptomatic.
- Individuals with special dietary requirements (eg vegetarians)
- People with eating disorders (eg. anorexia, bulimia)
- If any of the clinical screening results are indicative of a health problem which would affect the volunteers well-being or which would affect the study data.
- Refusal to give permission to inform GP of participation in study
- Allergic to any of the constituents of the test meal
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IFR
Norwich, Norfolk, NR4 7UA, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Alan R Mackie, PhD
Quadram Institute Bioscience
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2011
First Posted
April 11, 2011
Study Start
November 1, 2010
Primary Completion
June 1, 2012
Study Completion
June 1, 2012
Last Updated
June 22, 2012
Record last verified: 2012-06